• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYBoard
  • MYInsights
  • Strategy & Consulting
  • Contact Us
Select Page

My Lifestyle as Someone With Multiple Myeloma

by | Jul 11, 2024 | Uncategorized

Source: CureToday articles Side effects from multiple myeloma, such as six inches of collapsed vertebrae, have made me adjust my lifestyle, but I make the most of what I can. Read More

How Bispecific Antibodies Work to Treat Multiple Myeloma

by | Jul 8, 2024 | Uncategorized

Source: CureToday articles One expert explains how bispecific antibodies are a ‘targeted and effective’ option for patients with multiple myeloma. Read More

Mapping the Proteogenomic Landscape of Multiple Myeloma: Implications for Targeted Therapy

by | Jul 8, 2024 | Uncategorized

Source: Pharmacy Times articles Researchers identify significant proteins involved in the growth and survival of malignant multiple myeloma cells. Read More

VIDEO: ‘More movement’ in nontransplant-eligible multiple myeloma population

by | Jul 6, 2024 | Uncategorized

CHICAGO — In this video, Sandra Mazzoni, DO, highlights data in nontransplant-eligible patients with multiple myeloma presented at ASCO Annual Meeting.“There are a lot of studies in the nontransplant-eligible population presented, and I think that that space has not...

VIDEO: AI learning may reveal treatment outcome patterns in multiple myeloma

by | Jul 5, 2024 | Uncategorized

CHICAGO — Sandra Mazzoni, DO, spoke with Healio about a study presented at ASCO Annual Meeting she was part of investigating the use of AI to determine any patterns in how patients with multiple myeloma respond to therapy.“They used a database of hundreds of [patients...

Carvykti Associated With Improved Survival in R/R Multiple Myeloma

by | Jul 5, 2024 | Uncategorized

Source: CureToday articles Treatment with the CAR-T cell therapy Carvykti has been reported to improve survival among some patients with multiple myeloma. Read More
« Older Entries
Next Entries »

Recent Content

  • Unexpected Support in Tough Times With Multiple Myeloma
  • The AQUILA Debate: Daratumumab and Smoldering Multiple Myeloma
  • Quadruple Therapy With Isatuximab Shows Promise for Older Adults With Multiple Myeloma
  • Bortezomib, thalidomide, and dexamethasone versus bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma: a systemic review and meta-analysis
  • Myeloma cell-derived CXCL7 facilitates proliferation of tumor cells and occurrence of osteolytic lesions through JAK/STAT3 pathway
  • VDAC2 primes myeloma cells for BAK-dependent apoptosis and represents a novel therapeutic target
  • Management of CAR-T cell therapy in patients with multiple myeloma: a systematic review and expert consensus in Australia
  • Phase 1 clinical trial of B-Cell Maturation Antigen (BCMA) NEX-T® Chimeric Antigen Receptor (CAR) T cell therapy CC-98633/BMS-986354 in participants with triple-class exposed multiple myeloma
  • Exploring BCL2 regulation and upstream signaling transduction in venetoclax resistance in multiple myeloma: potential avenues for therapeutic intervention
  • Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS study
  • Facebook
  • X
  • Instagram
©2016-2024 MYELOMA360
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT